Xiaoqun Xu1,2, Houyong Zhu3, Huoyang Lv1. 1. a Department of Clinical Laboratory, Centre of Laboratory Medicine , Zhejiang Provincial People's Hospital, The Affiliated People's Hospital of Hangzhou Medical College , Hangzhou , Zhejiang , China. 2. b Zhejiang Chinese Medical University , Hangzhou , Zhejiang , China. 3. c Department of Cardiology , Hangzhou Hospital of Traditional Chinese Medicine; Hangzhou Dingqiao Hospital , Hangzhou , Zhejiang , China.
Abstract
PURPOSE: Two new Staphylococcus aureus vaccines, S. aureus four-antigen (SA4Ag) and three-antigen (SA3Ag) vaccines, have good immunogenicity and tolerance. However, the safety of these vaccines is worth exploring. Here, we performed a meta-analysis to investigate the safety of SA3Ag and SA4Ag by evaluating systemic and local adverse events. METHODS: The Medline, EMBASE, and Cochrane databases were searched for randomized clinical trials confirming the safety of SA4Ag and SA3Ag. Two investigators independently selected suitable trials, assessed trial quality, and extracted data. RESULTS: Three studies comprising a total of 1,148 participants were included in this review. The two S. aureus vaccines did not increase systemic adverse events (relative ratio 1.1 [95% confidence interval 0.98, 1.24]), but increased the incidence of local adverse events (2.89 [2.15, 3.90]). However, the incidence of severe local adverse events (4.06 [0.78, 21.24]) did not rise significantly. CONCLUSIONS: SA4Ag and SA3Ag have acceptable safety in adults.
PURPOSE: Two new Staphylococcus aureus vaccines, S. aureus four-antigen (SA4Ag) and three-antigen (SA3Ag) vaccines, have good immunogenicity and tolerance. However, the safety of these vaccines is worth exploring. Here, we performed a meta-analysis to investigate the safety of SA3Ag and SA4Ag by evaluating systemic and local adverse events. METHODS: The Medline, EMBASE, and Cochrane databases were searched for randomized clinical trials confirming the safety of SA4Ag and SA3Ag. Two investigators independently selected suitable trials, assessed trial quality, and extracted data. RESULTS: Three studies comprising a total of 1,148 participants were included in this review. The two S. aureus vaccines did not increase systemic adverse events (relative ratio 1.1 [95% confidence interval 0.98, 1.24]), but increased the incidence of local adverse events (2.89 [2.15, 3.90]). However, the incidence of severe local adverse events (4.06 [0.78, 21.24]) did not rise significantly. CONCLUSIONS:SA4Ag and SA3Ag have acceptable safety in adults.
Authors: Owoicho Adogwa; Aladine A Elsamadicy; Amanda Sergesketter; Victoria D Vuong; Ankit I Mehta; Raul A Vasquez; Joseph Cheng; Carlos A Bagley; Isaac O Karikari Journal: J Neurosurg Spine Date: 2017-06-30
Authors: Vance G Fowler; Keith B Allen; Edson D Moreira; Moustafa Moustafa; Frank Isgro; Helen W Boucher; G Ralph Corey; Yehuda Carmeli; Robert Betts; Jonathan S Hartzel; Ivan S F Chan; Tessie B McNeely; Nicholas A Kartsonis; Dalya Guris; Matthew T Onorato; Steven S Smugar; Mark J DiNubile; Ajoke Sobanjo-ter Meulen Journal: JAMA Date: 2013-04-03 Impact factor: 56.272
Authors: Louise O'Brien; Steven W Kerrigan; Gideon Kaw; Michael Hogan; José Penadés; David Litt; Desmond J Fitzgerald; Timothy J Foster; Dermot Cox Journal: Mol Microbiol Date: 2002-05 Impact factor: 3.501
Authors: Robert W Frenck; C Buddy Creech; Eric A Sheldon; David J Seiden; Martin K Kankam; James Baber; Edward Zito; Robin Hubler; Joseph Eiden; Joseph M Severs; Shite Sebastian; Jasdeep Nanra; Kathrin U Jansen; William C Gruber; Annaliesa S Anderson; Douglas Girgenti Journal: Vaccine Date: 2016-12-01 Impact factor: 3.641
Authors: Annaliesa S Anderson; Ingrid L Scully; Yekaterina Timofeyeva; Ellen Murphy; Lisa K McNeil; Terri Mininni; Lorna Nuñez; Marjolaine Carriere; Christine Singer; Deborah A Dilts; Kathrin U Jansen Journal: J Infect Dis Date: 2012-04-02 Impact factor: 5.226
Authors: Wouter Rozemeijer; Pamela Fink; Eduardo Rojas; C Hal Jones; Danka Pavliakova; Peter Giardina; Ellen Murphy; Paul Liberator; Qin Jiang; Douglas Girgenti; Remco P H Peters; Paul H M Savelkoul; Kathrin U Jansen; Annaliesa S Anderson; Jan Kluytmans Journal: PLoS One Date: 2015-02-26 Impact factor: 3.240
Authors: Dawid Pieper; Irma Hellbrecht; Linlu Zhao; Clemens Baur; Georgia Pick; Sarah Schneider; Thomas Harder; Kelsey Young; Andrea C Tricco; Ella Westhaver; Matthew Tunis Journal: Syst Rev Date: 2022-08-22